| |
| |
|
| Insider
Information: |
Beshar Luke M |
| Relationship: |
Director |
| City: |
East Rutherford |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
198,000 |
|
|
Indirect Shares
|
1,081 |
|
|
| Direct
Value |
$556,380 |
|
|
|
Indirect Value
|
$64,795 |
|
|
| Total
Shares |
199,081 |
|
|
| Total
Value |
$621,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cambrex Corp |
CBM |
Executive Vice President |
2007-10-10 |
0 |
2005-12-31 |
1,081 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
EVP & CFO |
2015-02-21 |
0 |
2011-01-31 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2018-11-29 |
0 |
2018-11-19 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2022-06-30 |
198,000 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-11-29 |
4 |
OE |
$3.76 |
$48,068 |
D/D |
12,784 |
12,784 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP &CFO |
• – – |
2011-01-31 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-10 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-29 |
4 |
OE |
$4.05 |
$19,643 |
D/D |
4,850 |
64,030 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-05-09 |
4 |
OE |
$4.05 |
$182,858 |
D/D |
45,150 |
104,330 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-09-16 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2022-03-14 |
4 |
B |
$4.25 |
$42,500 |
D/D |
10,000 |
188,000 |
2.39 |
% |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2022-03-10 |
4 |
B |
$4.46 |
$44,555 |
D/D |
10,000 |
178,000 |
2.39 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & CFO |
• – – |
2011-11-09 |
4 |
B |
$5.36 |
$107,200 |
D/D |
20,000 |
22,639 |
2.74 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-09-20 |
4 |
OE |
$5.71 |
$286,200 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive Vice President |
• – – |
2007-08-20 |
4 |
OE |
$7.39 |
$15,704 |
D/D |
2,125 |
31,442 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive Vice President |
• – – |
2007-10-02 |
4 |
OE |
$7.39 |
$47,111 |
D/D |
6,375 |
35,692 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-02-19 |
4 |
D |
$8.01 |
$55,029 |
D/D |
(6,870) |
59,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-12-12 |
4 |
OE |
$8.21 |
$496,735 |
D/D |
60,311 |
119,491 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-17 |
4 |
OE |
$8.21 |
$86,900 |
D/D |
7,422 |
75,201 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-02-07 |
4 |
D |
$8.61 |
$30,040 |
D/D |
(3,489) |
46,050 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP &CFO |
• – – |
2011-01-31 |
4 |
AS |
$10.00 |
$500,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive Vice President |
• – – |
2007-10-02 |
4 |
S |
$11.00 |
$137,500 |
D/D |
(12,500) |
23,192 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive Vice President |
• – – |
2007-10-10 |
4 |
S |
$11.01 |
$255,337 |
D/D |
(23,192) |
0 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-10 |
4 |
AS |
$12.00 |
$600,220 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-11-19 |
4 |
OE |
$12.74 |
$288,138 |
D/D |
12,116 |
12,116 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive Vice President |
• – – |
2007-08-20 |
4 |
S |
$13.25 |
$28,156 |
D/D |
(2,125) |
29,317 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-29 |
4 |
AS |
$14.00 |
$67,900 |
D/D |
(4,850) |
59,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-05-09 |
4 |
AS |
$14.18 |
$640,001 |
D/D |
(45,150) |
59,180 |
0 |
- |
|
| CBM |
Cambrex Corp |
Executive VP & CFO |
• – – |
2006-11-20 |
4 |
OE |
$18.68 |
$700,492 |
D/D |
36,544 |
59,453 |
0 |
- |
|
77 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
